Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.

Zeitlin, L.; Cone, R. A.; Whaley, K. J.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.

Published Date:

1999 Jan-Feb

Source:

Emerg Infect Dis. 5(1):54-64.

[PDF-162.11 KB]

Details:

Personal Authors:

Zeitlin, L. ; Cone, R. A. ; Whaley, K. J. ;

Keywords:

[+]

Description:

Passive immunization with antibodies has been shown to prevent a wide variety of diseases. Recent advances in monoclonal antibody technology are enabling the development of new methods for passive immunization of mucosal surfaces. Human monoclonal antibodies, produced rapidly, inexpensively, and in large quantities, may help prevent respiratory, diarrheal, and sexually transmitted diseases on a public health scale.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	10081672.nxml	text/plain
	license.txt	text/plain

No Related Documents.

You May Also Like:

SARS Vaccine Development

Personal Author:

Jiang, Shibo; He, Yuxian; Liu, Shuwen;

Published:

Jul 2005

Source:

Emerg Infect Dis. 11(7):1016-1020.

Description:

Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it ...

File Type:

[PDF - 95.26 KB]
Special Issue of journal Vaccine on AIDS Vaccine: Guest Editor’s Commentary

Personal Author:

Hankins, Catherine A.; Glasser, John W.; Chen, Robert T.;

Published:

Jul 14 2011

Source:

Vaccine. 29(36):6069-6071.

File Type:

[PDF - 75.80 KB]
Prospects for Universal Influenza Virus Vaccine

Personal Author:

Gerhard, Walter; Mozdzanowska, Krystyna; Zharikova, Darya;

Published:

Apr 2006

Source:

Emerg Infect Dis. 12(4):569-574.

Description:

The current vaccination strategy against influenza A and B viruses is vulnerable to the unanticipated emergence of epidemic strains that are poorly matched by the vaccine. A vaccine that is less sensitive to the antigenic evolution of the virus would...

File Type:

[PDF - 62.44 KB]
Fatal Infection of a Pet Monkey with Human herpesvirus 1

Personal Author:

Huemer, Hartwig P.; Larcher, Clara; Czedik-Eysenberg, Thomas; Nowotny, Norbert; Reifinger, Martin;

Published:

Jun 2002

Source:

Emerg Infect Dis. 8(6):639-641.

Description:

Concerns have been raised about pet monkeys as a potential threat to humans. We report the opposite situation, a danger to pets that arises from humans. Similar to herpesvirus B (Cercopithecine herpesvirus 1), which endangers humans but not its host ...

File Type:

[PDF - 1.08 MB]
Prevention of mother-to-child transmission of Human Immunodeficiency Virus Type 1 (HIV): the role of neonatal and infant prophylaxis

Personal Author:

Hurst, Stacey A.; Appelgren, Kristie E.; Kourtis, Athena P.;

Published:

Feb 2015

Source:

Expert Rev Anti Infect Ther. 13(2):169-181

Description:

The prevention of mother-to-child transmission (PMTCT) of HIV is one of the great public health successes of the past 20 years. Much concerted research efforts and dedicated work have led to the achievement of very low rates of PMTCT of HIV in settin...

File Type:

[PDF - 166.63 KB]